- Filed
- Mar 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 10, 2026 | 35.43M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 34.06M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 30.06M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$3.95M |
| Operating Cash Flow restated | FY 2025 · Dec 31, 2024 | $6.16M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $1.19M |
| Cash And Equivalents restated | FY 2025 · Dec 31, 2024 | $2.25M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$4.61M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2024 | $62.77M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2023 | $34.96M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $24.34M |
| Current Liabilities restated | FY 2025 · Dec 31, 2024 | $21.27M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $70.48M |
| Total Liabilities restated | FY 2025 · Dec 31, 2024 | $61.1M |
| Current Assets | FY 2025 · Dec 31, 2025 | $8.18M |
| Current Assets restated | FY 2025 · Dec 31, 2024 | $12.35M |
| Total Assets | FY 2025 · Dec 31, 2025 | $65.87M |
| Total Assets restated | FY 2025 · Dec 31, 2024 | $123.87M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$2.12 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.54 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$2.12 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$0.54 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $13.42M |
| Sga Expense restated | FY 2025 · Dec 31, 2024 | $14.74M |
| Net Income | FY 2025 · Dec 31, 2025 | −$72.07M |
| Net Income restated | FY 2025 · Dec 31, 2024 | −$16.2M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$71.32M |
| Operating Income restated | FY 2025 · Dec 31, 2024 | −$13.67M |
| Revenue | FY 2025 · Dec 31, 2025 | $34.2M |
| Revenue restated | FY 2025 · Dec 31, 2024 | $43.65M |